Cardiovascular disease is the leading cause of death and has dramatically increased in
recent years. Continuous cardiac monitoring is particularly important for early diagnosis and …

Heart failure (HF) is a leading cause of morbidity and mortality in the United States. Despite
a number of important therapeutic advances for the treatment of symptomatic HF, 1 the …

Driven by enormous clinical need, myocardial tissue engineering has become a prime focus
of research within the field of tissue engineering. Myocardial tissue engineering combines …

Objectives: This study sought to determine whether alginate biomaterial can be delivered
effectively into the infarcted myocardium by intracoronary injection to prevent left ventricular …

For nearly a decade, researchers have investigated the possibility of cell transplantation for
cardiac repair. More recently, the emerging fields of tissue engineering and biomaterials …

OBJECTIVE: The study objective was to evaluate in a prospective, randomized, multicenter
trial the safety and efficacy of mitral valve surgery with and without the CorCap cardiac …

The American Heart Association makes every effort to avoid any actual or potential conflicts
of interest that may arise as a result of an outside relationship or a personal, professional, or …

Cardiac resynchronization therapy (CRT) presents effective means to modulate cardiac
conduction and related functions in heart failure patients. However, the conventional CRT …

Heart failure is the major cause of mortality in Western countries. Medical treatment of heart
failure is associated with 50% survival at 5 years. Experimental models are required to better …

BACKGROUND: Left ventricular (LV) remodeling is related to adverse outcomes in heart
failure. The CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, MN) …